Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
Top 10 pharmaceutical companies in 2024: S&P Global's latest ratings and rankings
01:57pm, Monday, 19'th Aug 2024
In the ever-evolving pharmaceutical landscape, financial stability and business resilience are crucial for long-term success. S&P Global, a leading financial information firm, recently released a comp
Novo Nordisk A/S - share repurchase programme
08:48am, Monday, 19'th Aug 2024
Bagsværd, Denmark, 19 August 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Counc
Prediction: These 2 Unstoppable Pharma Stocks Will Continue to Soar Through 2025 and Beyond
05:11am, Monday, 19'th Aug 2024
Novo Nordisk and Eli Lilly won't be constrained by manufacturing too much longer. That means they'll sell more of their in-demand drugs.
Novo Nordisk: Great Value Buying Opportunity, Thanks To The Much-Needed Rotation
10:00am, Sunday, 18'th Aug 2024
The recent market correction and market's overreaction to the supposedly softer Wegovy sales have triggered NVO's discounted entry points. With Ozempic/Wegovy no longer in shortage and manufacturing c
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
06:12am, Sunday, 18'th Aug 2024
The anti-obesity market is a huge growth opportunity in healthcare. Novo Nordisk and Eli Lilly dominate it today, but it may not be long before there's more competition.
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year
03:19am, Sunday, 18'th Aug 2024
Keytruda, Humira, and Ozempic generated a combined $53 billion in sales last year. The companies that make these drugs generate a lot of their sales from them.
3 Fantastic Growth Stocks to Buy in August
07:30am, Saturday, 17'th Aug 2024
Eli Lilly is a biopharma giant that could still deliver strong growth. Novo Nordisk's growth story isn't over thanks to Ozempic, Wegovy, and a promising pipeline.
Novo Nordisk Pharmatech unit to build $220 mln plant in Denmark
01:31am, Friday, 16'th Aug 2024
Novo Nordisk's Pharmatech unit will build a 1.5 billion Danish crowns ($220.83 million) plant in Denmark to meet significantly higher demand for the production of medicines to fight chronic diseases,
Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA Negotiations
09:06am, Thursday, 15'th Aug 2024
Diabetes treatments from Merck, Novo Nordisk and AstraZeneca will face the steepest cuts under the IRA, a list showed Thursday.
Is Novo Nordisk's Earnings Miss a Cause for Concern for Investors?
05:25am, Thursday, 15'th Aug 2024
Novo Nordisk's recent earnings numbers came in slightly lower than expectations. The company also reduced its forecast for earnings growth this year.
Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock
10:06am, Wednesday, 14'th Aug 2024
Novo Nordisk (NVO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
07:40am, Wednesday, 14'th Aug 2024
Bagsværd, Denmark, 14 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated pe
3 Stable Blue-Chip Stocks to Buy for the Market Storm
06:15am, Wednesday, 14'th Aug 2024
The volatility that has rocked markets since the beginning of July might not be over just yet. August has proven to be extremely rocky.
Here's How to Play Novo Nordisk (NVO) After Q2 Earnings Miss
12:36pm, Tuesday, 13'th Aug 2024
Novo Nordisk (NVO) is an excellent stock to buy for long-term gains, driven by the stellar performance of its GLP-1 drugs. New investors should utilize the existing opportunity to make an entry.
Why Novo Nordisk (NVO) is a Top Growth Stock for the Long-Term
10:45am, Tuesday, 13'th Aug 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
